Returns on R&D tumble at world's top drugmakers
by on Nov.21, 2011, under Health and Fitness
Investment returns from researching new drugs have fallen nearly 30 percent in the past year at the world's 12 top pharmaceutical companies, highlighting the productivity dilemma facing the sector, according to a report on Monday.
View full post on Yahoo! Health News
